Cargando…
MiR-135a inhibits non-small cell lung cancer progression by suppressing RAB1B expression and the RAS pathway
Lung cancer is the most common tumor in China and worldwide. Despite advances in diagnosis and therapy, it still represents the most lethal malignancy in industrialized countries. The study of regulatory noncoding RNAs has deepened our understanding of cancer on the molecular and clinical level. In...
Autores principales: | Tian, Ye, Zhang, Lei, Yu, Qian, Wang, Zelong, Yang, Xueying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425451/ https://www.ncbi.nlm.nih.gov/pubmed/32710726 http://dx.doi.org/10.18632/aging.103494 |
Ejemplares similares
-
Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
por: Di, Yuzhu, et al.
Publicado: (2021) -
Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
por: Di, Yuzhu, et al.
Publicado: (2021) -
miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα
por: Tribollet, Violaine, et al.
Publicado: (2016) -
miR-135a promotes gastric cancer progression and resistance to oxaliplatin
por: Yan, Lin-Hai, et al.
Publicado: (2016) -
Inhibition of the miR-192/215–Rab11-FIP2 axis suppresses human gastric cancer progression
por: Zhang, Xiaojing, et al.
Publicado: (2018)